Symmetry Partners, LLC Eli Lilly & CO Transaction History

Symmetry Partners, LLC

$1.94 Billion
Q2 2024

A detailed history of Symmetry Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Symmetry Partners, LLC holds 11,272 shares of LLY stock, worth $10.2 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

11,272

Previous 15,194 25.81%

Holding current value

$10.2 Million

Previous $11.8 Million 13.66%

% of portfolio

0.53%

Previous 0.93%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$724.87 - $909.04 $2.84 Million - $3.57 Million	-3,922 Reduced 25.81%	11,272 $10.2 Million
Q4 2023 Jan 02, 2024	SELL	$525.19 - $619.13 $493,153 - $581,363	-939 Reduced 5.82%	15,194 $8.83 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $188,659 - $260,096	-434 Reduced 2.62%	16,133 $8.67 Million
Q1 2023 Apr 03, 2023	BUY	$310.63 - $364.82 $117,728 - $138,266	379 Added 2.34%	16,567 $5.69 Million
Q3 2022 Oct 03, 2022	SELL	$296.48 - $337.87 $45,954 - $52,369	-155 Reduced 0.95%	16,188 $5.23 Million
Q2 2022 Jul 11, 2022	BUY	$278.73 - $327.27 $1.15 Million - $1.35 Million	4,128 Added 33.79%	16,343 $5.3 Million
Q1 2022 Apr 04, 2022	BUY	$234.69 - $291.66 $301,811 - $375,074	1,286 Added 11.77%	12,215 $3.5 Million
Q4 2021 Jan 11, 2022	BUY	$224.85 - $279.04 $898,950 - $1.12 Million	3,998 Added 57.68%	10,929 $3.02 Million
Q3 2021 Oct 18, 2021	SELL	$221.6 - $272.71 $59,388 - $73,086	-268 Reduced 3.72%	6,931 $1.6 Million
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $180,259 - $233,353	-1,097 Reduced 13.22%	7,199 $1.35 Million
Q4 2020 Feb 18, 2021	SELL	$130.46 - $172.63 $410,427 - $543,093	-3,146 Reduced 27.5%	8,296 $1.4 Million
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $645,999 - $747,216	4,418 Added 62.9%	11,442 $1.69 Million
Q2 2020 Jul 20, 2020	BUY	$136.42 - $164.18 $958,214 - $1.15 Million	7,024 New	7,024 $1.15 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $841,032 - $1.04 Million	-7,866 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $723,609 - $787,100	-6,776 Reduced 46.28%	7,866 $880,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $234,542 - $273,770	-2,117 Reduced 12.63%	14,642 $1.62 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $903,948 - $1.06 Million	8,121 Added 94.01%	16,759 $2.18 Million
Q4 2018 May 22, 2019	BUY	$105.9 - $118.64 $914,764 - $1.02 Million	8,638 New	8,638 $1 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.

Account

Symmetry Partners, LLC Eli Lilly & CO Transaction History